Impulse control and repetitive behaviors in Parkinson's disease - Are there differences in the relation to dopamine agonist treatment?

被引:0
|
作者
Hatteland Somme, Johanne [1 ,2 ]
Carlos Gomez-Esteban, Juan [1 ]
Tijero, Beatriz [1 ]
Berganzo, Koldo [1 ]
Lezcano, Elena [1 ]
Jose Zarranz, Juan [1 ]
机构
[1] Univ Basque Country, Movement Disorders Unit, Serv Vasco Salud Osakidetza, Dept Neurol,Cruces Univ Hosp,Dept Neurosci, Bilbao, Spain
[2] Alava Univ Hosp, Dept Neurol, Serv Vasco Salud Osakidetza, Vitoria, Spain
关键词
Parkinson's disease; Impulse control disorders; Dopamine agonists; Levodopa; Neuropsychiatry; Punding; CONTROL DISORDERS; ROTIGOTINE;
D O I
10.1016/j.jns.2014.07.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:252 / 253
页数:2
相关论文
共 50 条
  • [41] Screening for impulse control disorders in Parkinson’s disease and dopamine agonist use: a study of pharmacokinetic and psychological risk factors
    Manuela Contin
    Giovanna Lopane
    Luca Marini
    Susan Mohamed
    Luisa Sambati
    Patrizia De Massis
    Maria Guarino
    Simonetta Sermi
    Chiara Persichella
    Pietro Cortelli
    Giovanna Calandra-Buonaura
    Neurological Sciences, 2023, 44 : 565 - 572
  • [43] Disabling repetitive behaviors in Parkinson's disease
    Kurlan, R
    MOVEMENT DISORDERS, 2004, 19 (04) : 433 - 437
  • [44] Dopamine agonist-based strategies in the treatment of Parkinson’s disease
    Angelo Antonini
    Paolo Barone
    Neurological Sciences, 2008, 29 : 371 - 374
  • [45] Introduction: pramipexole: a novel dopamine agonist for the treatment of Parkinson's disease
    de Yebenes, JG
    EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 : 1 - 2
  • [46] Use of the dopamine receptor agonist Mirapex in the treatment of Parkinson's disease
    Fedorova N.V.
    Chigir' I.P.
    Neuroscience and Behavioral Physiology, 2007, 37 (6) : 539 - 546
  • [47] Dopamine agonist-based strategies in the treatment of Parkinson's disease
    Antonini, Angelo
    Barone, Paolo
    NEUROLOGICAL SCIENCES, 2008, 29 (Suppl 5) : S371 - S374
  • [48] Rotigotine: A novel dopamine agonist for the transdermal treatment of Parkinson's disease
    Zareba, G
    DRUGS OF TODAY, 2006, 42 (01): : 21 - 28
  • [49] Dopamine agonist monotherapy in Parkinson's disease
    Clarke, CE
    Guttman, M
    LANCET, 2002, 360 (9347): : 1767 - 1769
  • [50] Dopamine agonist switching in Parkinson's disease
    Stewart, D
    Morgan, E
    Burn, D
    Grosset, D
    Chaudhuri, KR
    MacMahon, D
    Needleman, F
    Macphee, G
    Heywood, P
    HOSPITAL MEDICINE, 2004, 65 (04): : 215 - 219